0.5647
price down icon0.93%   -0.0053
after-market Dopo l'orario di chiusura: .56 -0.0047 -0.83%
loading
Precedente Chiudi:
$0.57
Aprire:
$0.57
Volume 24 ore:
672.43K
Relative Volume:
0.06
Capitalizzazione di mercato:
$24.97M
Reddito:
$106.79M
Utile/perdita netta:
$-8.73M
Rapporto P/E:
-2.8235
EPS:
-0.2
Flusso di cassa netto:
$10.81M
1 W Prestazione:
+25.24%
1M Prestazione:
+14.31%
6M Prestazione:
-67.55%
1 anno Prestazione:
-83.14%
Intervallo 1D:
Value
$0.55
$0.58
Intervallo di 1 settimana:
Value
$0.443
$0.64
Portata 52W:
Value
$0.2813
$3.43

Harvard Bioscience Inc Stock (HBIO) Company Profile

Name
Nome
Harvard Bioscience Inc
Name
Telefono
(508) 893-8999
Name
Indirizzo
84 OCTOBER HILL RD, HOLLISTON, MA
Name
Dipendente
355
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-12
Name
Ultimi documenti SEC
Name
HBIO's Discussions on Twitter

Confronta HBIO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Instruments & Supplies icon
HBIO
Harvard Bioscience Inc
0.5647 25.20M 106.79M -8.73M 10.81M -0.20
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
495.86 175.16B 9.15B 2.61B 1.99B 7.17
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
185.32 52.63B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
ALC
Alcon Inc
91.86 45.46B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
RMD
Resmed Inc
275.16 40.10B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
263.51 20.05B 2.90B 467.20M 306.90M 6.37

Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-09 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
2023-03-10 Aggiornamento The Benchmark Company Speculative Buy → Buy
2021-01-07 Aggiornamento The Benchmark Company Speculative Buy → Buy
2020-12-09 Iniziato Northland Capital Outperform
2020-11-10 Iniziato KeyBanc Capital Markets Overweight
2019-07-08 Downgrade Janney Buy → Neutral
2018-01-24 Reiterato Janney Buy
2018-01-23 Reiterato The Benchmark Company Buy
2016-11-17 Iniziato Singular Research Buy
2015-07-28 Iniziato The Benchmark Company Buy
Mostra tutto

Harvard Bioscience Inc Borsa (HBIO) Ultime notizie

pulisher
07:30 AM

What analysts say about Harvard Bioscience Inc. stockMarket-leading growth rates - Autocar Professional

07:30 AM
pulisher
01:03 AM

What makes Harvard Bioscience Inc. stock price move sharplyFree Access to Investment Community - Newser

01:03 AM
pulisher
12:55 PM

What makes Harvard Bioscience Inc. stock attractive to long term investorsSkyrocketing returns - jammulinksnews.com

12:55 PM
pulisher
12:46 PM

Why Harvard Bioscience Inc. stock attracts strong analyst attentionDouble Profit With Half Risk - Newser

12:46 PM
pulisher
Jul 23, 2025

What drives Harvard Bioscience Inc. stock priceHigh-performance investment picks - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Does Harvard Bioscience (NASDAQ:HBIO) Have A Healthy Balance Sheet? - simplywall.st

Jul 23, 2025
pulisher
Jul 22, 2025

Is Harvard Bioscience Inc. a good long term investmentExceptional gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Harvard Bioscience Inc. Stock Analysis and ForecastBreakout portfolio performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 20, 2025

Harvard Bioscience announces CEO succession plan - MSN

Jul 20, 2025
pulisher
Jul 18, 2025

Harvard Bioscience stock holds Speculative Buy rating at Benchmark - Investing.com India

Jul 18, 2025
pulisher
Jul 18, 2025

Harvard Bioscience stock holds Speculative Buy rating at Benchmark By Investing.com - Investing.com Canada

Jul 18, 2025
pulisher
Jul 17, 2025

Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board - GlobeNewswire

Jul 17, 2025
pulisher
Jul 17, 2025

John Duke Appointed CEO of Harvard Bioscience - citybiz

Jul 17, 2025
pulisher
Jul 17, 2025

Harvard Bioscience Announces CEO Succession Plan - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Harvard Bioscience names John Duke as new CEO as Jim Green retires By Investing.com - Investing.com South Africa

Jul 17, 2025
pulisher
Jul 17, 2025

Harvard Bioscience names John Duke as new CEO as Jim Green retires - Investing.com

Jul 17, 2025
pulisher
Jul 17, 2025

Harvard Bioscience Announces John Duke as New President & CEO Following Jim Green's Retirement and Appoints Rob Gagnon and Seth Benson to Board of Directors - Quiver Quantitative

Jul 17, 2025
pulisher
Jul 15, 2025

How Harvard Bioscience Inc. stock performs during market volatilitySafe and Scalable Investment Tips - Newser

Jul 15, 2025

Harvard Bioscience Inc Azioni (HBIO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$74.75
price up icon 1.11%
$66.50
price up icon 0.61%
medical_instruments_supplies COO
$74.59
price up icon 1.07%
$205.56
price up icon 1.67%
medical_instruments_supplies BAX
$29.22
price up icon 1.56%
medical_instruments_supplies WST
$263.51
price down icon 5.59%
Capitalizzazione:     |  Volume (24 ore):